Allotment

Dr. Agarwal’s Health Care is launching an IPO through a book-building issue of ₹3,027.26 crore. The issue comprises a fresh issue of 0.75 crore shares aggregating to ₹300.00 crore and an offer for sale of 6.78 crore shares worth ₹2,727.26 crore. Proceeds from the fresh issue will be utilized by the company, while the offer for sale proceeds will be received by the selling shareholders.
Issue Details
The price band for the IPO is fixed at ₹402 per share. The lot size for an application is 35 shares, and investors can bid in multiples of 35 shares. Retail investors can participate with a minimum investment of ₹14,070, while the minimum investment for sNII is 525 shares (15 lots) amounting to ₹2,11,050, and for bNII, it is 2,520 shares (72 lots) totaling ₹10,13,040. The IPO also includes a reservation of up to 15,79,399 shares for employees, offered at no discount to the issue price.
Timeline
The IPO opened on January 29, 2025, and closed on January 31, 2025. The allotment was finalized on February 3, 2025, and the shares were subsequently listed on BSE and NSE on February 4, 2025.
Key Participants
Kotak Mahindra Capital Company Ltd. is the Book Running Lead Manager, while Kfin Technologies Ltd. serves as the Registrar of the Issue.
₹4020%
Open
HIgh - Low
Previous Close
Total Traded Value
52 Weeks High
52 Weeks Low
Updates On
IPO. Open
IPO. Close
IPO. Price
IPO Market price
| IPO Date | 4 Feb |
| IPO Listing Date | 4 Feb |
| IPO Face Value | ₹1 per share |
| IPO Price Range | ₹402.00 |
| IPO Issue Size | 7,53,04,970 shares |
| IPO Sale Type | Fresh Capital & OFS |
| Employee Discount | - |
| IPO Issue Type | Bookbuilding IPO |
| IPO Listing | BSE, NSE Platform |
| hare Holding Pre Issue | 30,84,17,160 shares |
| IPO Open Date | 29 Jan |
| IPO Close Date | 31 Jan |
| IPO Allotment (Tentative) | 3 Feb |
| Refunds | 4 Feb |
| Credit to Demat Account | 4 Feb |
| IPO Listing Date | 4 Feb |
| Category | Offer |
|---|---|
| QIB Shares Offered | 3,62,97,99 Shares |
| NII (HNI) Shares Offered | 1,08,89,400 Shares |
| Retail Shares Offered | 2,54,08,599 Shares |
Investors may apply for a minimum of 35 shares and in multiples of 35 shares thereafter.
| Application | Lots | Share | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 35 | ₹14,070 |
| Retail (Max) | 14 | 490 | ₹1,96,980 |
| S-HNI (Min) | 15 | 525 | ₹2,11,050 |
| S-HNI (Max) | 71 | 2,485 | ₹9,98,970 |
| B-HNI (Min) | 72 | 2,520 | ₹10,13,040 |
Incorporated in 2010, Dr. Agarwal’s Health Care Limited is one of India’s leading providers of comprehensive eye care services. The company offers a wide spectrum of treatments, including cataract and refractive surgeries, consultations, diagnostics, non-surgical treatments, and the retail sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.
Clinical Scale and Performance
As of September 30, 2024, the company had a team of 737 doctors delivering care across its facilities. During this period, it served 2.13 million patients and performed 220,523 surgeries. In the six months ended September 30, 2024 alone, the company treated 1.15 million patients and conducted 140,787 surgical procedures, highlighting strong patient volumes and clinical throughput.
Services and Network
Dr. Agarwal’s Health Care provides a broad range of eye care services, including cataract surgeries (such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens procedures), refractive surgeries (LASIK, SMILE, implantable collamer lenses, and PRK), and other specialized surgeries covering retinal treatments, corneal transplantation, oculoplasty, glaucoma, and pterygium. As of September 30, 2024, its Indian network comprised 28 hubs (including three Centres of Excellence) and 165 spokes, operating across 193 facilities in 117 metro and non-metro cities spanning 14 states and four union territories.
Competitive Strengths
The company’s competitive advantages include its position as the largest eye care services provider in India, a trusted and established brand, a comprehensive end-to-end service offering, and a scalable, asset-light hub-and-spoke operating model. Its proven clinical excellence is driven by doctor-promoters, a strong clinical board, continuous surgical innovation, and an experienced management team, supported by a consistent track record of organic growth, successful acquisitions, and improving profitability.
| Assets | 3,393.41 | 2,752.82 | 1,825.17 |
| Total Income | 837.94 | 1,376.45 | 1,031.49 |
| Profit After Tax | 39.56 | 95.05 | 103.23 |
| EBITDA | - | - | - |
| NET Worth | 1,502.67 | 1,337.68 | 627.83 |
| Reserves and Surplus | 1,509.11 | 1,365.86 | 652.63 |
| Total Borrowing | 373.68 | 387.79 | 356.18 |
| ROE | 9.33% |
| ROCE | 14.61% |
| Debt/Equity | - |
| RoNW | 6.21 |
| PAT Margin | 6.90% |
| EBITDA Margin | - |
| Price to Book Value | 7.96 |
IPO Objects of the Issue
| S.No. | Objects of the ipo Resources Detail | IPO Amount |
|---|---|---|
| 1 | Funding capital expenditure requirements for the purchase of equipment/machineries | - |
| 2 | To meet out the expenses of Working Capital Requirement | - |
| 3 | To meet out the General Corporate Purposes; | 77.47 |
| 4 | Offer for Sale (OFS) | - |
Dr.Agarwal’s Health Care Ltd. Address
1 st Floor, Buhari Towers
No.4, Moores Road, Off Greams Road,
Near Asan Memorial School, Chennai 600 006
Chennai, Tamil Nadu
+91 44 4378 7777
secretarial@dragarwal.com
IPO Registrar
Kfin Technologies Ltd.
04067162222, 04079611000
ahcl.ipo@kfintech.com
https://ipostatus.kfintech.com/